Chargement en cours...

Candidates for thrombolytic treatment in acute ischaemic stroke--where are our patients in Hong Kong?

OBJECTIVE: Tissue plasminogen activator (t-PA) has been approved by the Food and Drug Administration in the treatment of patients with acute ischaemic stroke presenting within three hours from onset of symptoms. This study aims to identify the potential number of stroke patients suitable for t-PA in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Siu, Y C, Wong, T W, Lau, C C
Format: Artigo
Langue:Inglês
Publié: 1999
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1343404/
https://ncbi.nlm.nih.gov/pubmed/10572812
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!